Aminomethylbenzoic acid


Generic Medicine Info
Indications and Dosage
Oral
Antifibrinolytic
Adult: 0.3-1 g daily, in 3-4 divided doses. May also be given via IM or IV inj.
Contraindications
Active intravascular clotting.
Special Precautions
Caution when used in patients with thromboembolic disorders.
Adverse Reactions
GI discomfort, diarrhoea, nausea, vomiting.
Drug Interactions
Concurrent use with factor IX complex or anti-inhibitor coagulant concentrates may increase risk of thrombosis.
Action
Description:
Mechanism of Action: Aminomethylbenzoic acid is an antifibrinolytic drug that inhibits breakdown of fibrin clots.
MIMS Class
Haemostatics
Disclaimer: This information is independently developed by MIMS based on Aminomethylbenzoic acid from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in